Skip to content
  • Reports
  • Podcast Subscribe
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Horama

Horama

ADVERTISEMENT
In Depth

Can Gene Therapy Cure Blindness?

Since the approval of the first gene therapy for blindness, there has been a wave…

By Clara Rodríguez Fernández
March 10, 2021 - 7 minutes
Best in Biotech

The Top 20 Women in Leading Biotech Roles in Europe

The biotech industry has often been criticized for its lack of gender diversity. While there…

By Jonathan Smith
May 21, 2019 - 12 minutes
Interview

How to Overcome Failure as a Biotech Company

Turning failure into success is a difficult but much needed skill in a high-risk industry…

By Clara Rodríguez Fernández
September 25, 2018 - 4 minutes
News and Trends

Update: French Biotech Raises €22M for a Gene Therapy Trial in Retinitis Pigmentosa

Update (18/09/2018): Horama has increased the total raised in its Series B fundraising to €22.5M,…

By Clara Rodríguez Fernández
September 18, 2018 - 2 minutes
News and Trends

Gene Therapy for Retinitis Pigmentosa Tested in Humans for the First Time

French biotech Horama has treated the first patients with a gene therapy for retinitis pigmentosa…

By Clara Rodríguez Fernández
July 11, 2018 - 3 minutes
Best in Biotech

The Biggest Biotech News of 2017: What Happened This Year?

Still catching up on news? We've picked out the most exciting things that happened besides…

By Evelyn Warner
December 27, 2017 - 3 minutes
News and Trends

French Gene Therapy to Cure Retinitis Pigmentosa Enters the Clinic

Horama has been authorized to start a Phase I/II trial in France testing HORA-PDE6B, a…

By Clara Rodríguez Fernández
October 11, 2017 - 3 minutes
News and Trends

French Startup raised €4M for Gene Therapy to fix specific Types of Blindness

Horama is developing gene therapies for several hereditary retinal dystrophies. It has now raised €4M…

By Denise Neves Gameiro
July 8, 2016 - 2 minutes
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Gene therapy Synthetic biology
    Labiotech.eu
    • Log In

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast
    • Biotech Events
    • Awareness Days